2018 대한부정맥학회 비판막성 심방세동 환자의 동율동 조절 약제 지침
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강기운 | - |
dc.contributor.author | 심재민 | - |
dc.contributor.author | 안진희 | - |
dc.contributor.author | 이대인 | - |
dc.contributor.author | 김준 | - |
dc.contributor.author | 정보영 | - |
dc.contributor.author | 최기준 | - |
dc.date.accessioned | 2024-02-27T10:01:38Z | - |
dc.date.available | 2024-02-27T10:01:38Z | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 1738-9364 | - |
dc.identifier.issn | 2289-0769 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/72525 | - |
dc.description.abstract | Rhythm control therapy is the main strategy for restoring and maintaining sinus rhythm in patients with non-valvular atrial fibrillation (NVAF). Sinus rhythm is better restored and maintained with antiarrhythmic drugs than with placebo treatment. In addition, catheter ablation or combination therapy is more effective than antiarrhythmic drugs for treating NVAF. However, in most clinical trials to date, rhythm control therapy has resulted in neutral clinical outcomes compared with rate control therapy. The decision to undergo rhythm control therapy should be based on age, atrial fibrillation (AF)-related symptoms, type of AF, structural heart disease, and underlying comorbidities. For now, rhythm control therapy is indicated to improve symptoms in patients with NVAF who have refractory symptoms after adequate rate control therapy. The Korean Heart Rhythm Society organized the Korean AF Management Guideline Committee and analyzed all available data, including South Korean patients with NVAF. This review article provides general principles and detailed methodology for rhythm control therapy in South Korean patients with NVAF. | - |
dc.format.extent | 13 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한내과학회 | - |
dc.title | 2018 대한부정맥학회 비판막성 심방세동 환자의 동율동 조절 약제 지침 | - |
dc.title.alternative | 2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | 대한내과학회지, v.93, no.2, pp 140 - 152 | - |
dc.identifier.kciid | ART002332794 | - |
dc.description.isOpenAccess | Y | - |
dc.citation.endPage | 152 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 140 | - |
dc.citation.title | 대한내과학회지 | - |
dc.citation.volume | 93 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | 심방세동 | - |
dc.subject.keywordAuthor | 항부정맥제 | - |
dc.subject.keywordAuthor | 가이드라인 | - |
dc.subject.keywordAuthor | Atrial fibrillation | - |
dc.subject.keywordAuthor | Anti-arrhythmia agents | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.